MedApp Inkomsten in het verleden

Verleden criteriumcontroles 0/6

MedApp's earnings have been declining at an average annual rate of -30.5%, while the Healthcare Services industry saw earnings growing at 6.8% annually. Revenues have been growing at an average rate of 12.3% per year.

Belangrijke informatie

-30.5%

Groei van de winst

-29.7%

Groei van de winst per aandeel

Healthcare Services Groei van de industrie16.1%
Inkomstengroei12.3%
Rendement op eigen vermogen-15.5%
Nettomarge-77.1%
Volgende winstupdate14 Nov 2024

Recente prestatie-updates uit het verleden

Recent updates

Why Investors Shouldn't Be Surprised By MedApp S.A.'s (WSE:MDA) 26% Share Price Surge

Mar 26
Why Investors Shouldn't Be Surprised By MedApp S.A.'s (WSE:MDA) 26% Share Price Surge

Is It Too Late To Consider Buying MedApp S.A. (WSE:MDA)?

Jan 29
Is It Too Late To Consider Buying MedApp S.A. (WSE:MDA)?

Can You Imagine How Jubilant MedApp's (WSE:MDA) Shareholders Feel About Its 292% Share Price Gain?

Mar 12
Can You Imagine How Jubilant MedApp's (WSE:MDA) Shareholders Feel About Its 292% Share Price Gain?

MedApp S.A.'s (WSE:MDA) Stock Is Going Strong: Have Financials A Role To Play?

Jan 18
MedApp S.A.'s (WSE:MDA) Stock Is Going Strong: Have Financials A Role To Play?

Announcing: MedApp (WSE:MDA) Stock Soared An Exciting 363% In The Last Five Years

Nov 26
Announcing: MedApp (WSE:MDA) Stock Soared An Exciting 363% In The Last Five Years

Opbrengsten en kosten

Hoe MedApp geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.


Inkomsten en omzetgeschiedenis

WSE:MDA Opbrengsten, kosten en inkomsten (PLN Millions )
DatumInkomstenInkomstenG+A UitgavenR&D-uitgaven
30 Jun 245-440
31 Mar 245-240
31 Dec 236-340
30 Sep 235-240
30 Jun 236040
31 Mar 236040
31 Dec 227150
30 Sep 229250
30 Jun 2212350
31 Mar 2214460
31 Dec 2113450
30 Sep 2114760
30 Jun 2111550
31 Mar 218340
31 Dec 206230
30 Sep 204130
30 Jun 203020
31 Mar 203020
31 Dec 193120
30 Sep 1900-10
30 Jun 190000
31 Mar 190-100
31 Dec 180-220
30 Sep 180-450
30 Jun 180-440
31 Mar 180-330
31 Dec 170-220
30 Sep 170-110
30 Jun 170-110
31 Mar 170-110
31 Dec 160-110
30 Sep 160-110
31 Mar 160-100
31 Dec 150-100
30 Sep 150-110
31 Mar 151010
31 Dec 141-110
30 Sep 141-510
30 Jun 141-320
31 Mar 141-410
31 Dec 132-410

Kwaliteitswinsten: MDA is currently unprofitable.

Groeiende winstmarge: MDA is currently unprofitable.


Analyse vrije kasstroom versus winst


Analyse van de winstgroei in het verleden

Winsttrend: MDA is unprofitable, and losses have increased over the past 5 years at a rate of 30.5% per year.

Versnelling van de groei: Unable to compare MDA's earnings growth over the past year to its 5-year average as it is currently unprofitable

Winst versus industrie: MDA is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (7.1%).


Rendement op eigen vermogen

Hoge ROE: MDA has a negative Return on Equity (-15.48%), as it is currently unprofitable.


Rendement op activa


Rendement op geïnvesteerd vermogen


Ontdek sterk presterende bedrijven uit het verleden